Gates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingGates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement
PATH – Aridis, Rotavirus Vaccine Development Agreement Post author:GHIAA Admin Post published:January 7, 2022 Post category: Continue ReadingPATH – Aridis, Rotavirus Vaccine Development Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 26, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Admin Post published:December 15, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
US Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement Post author:GHIAA Admin Post published:September 9, 2021 Post category: Continue ReadingUS Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement
CEPI – Valneva, Chikungunya Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 24, 2021 Post category: Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement
NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments